Yongjun Chen
Clinical trials sponsored by Yongjun Chen, explained in plain language.
-
Does removing blood vessels boost survival in bile duct cancer surgery?
Knowledge-focused Not yet recruitingThis study reviews past medical records of 300 people who had surgery for a rare and aggressive bile duct cancer called hilar cholangiocarcinoma. It aims to see if also removing nearby blood vessels during the operation helps patients live longer and have fewer complications. The…
Sponsor: Yongjun Chen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New study tests smaller liver surgery for tough bile duct cancers
Knowledge-focused Not yet recruitingThis study looks at a type of liver surgery called volume-restricted resection for patients with a rare bile duct cancer (perihilar cholangiocarcinoma) whose liver is too small after standard surgery. Researchers will follow 300 patients who get this surgery or non-surgical care …
Sponsor: Yongjun Chen • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:15 UTC